Plasma level of neopterin as a marker of disease activity in treated rheumatoid arthritis patients: Association with gender, disease activity and anti-CCP antibody

International Immunopharmacology

Volumn 17, Issue 3, 2013, Pages 763-767

  Arshadi, Delnia ^a,b   Nikbin, Behrouz ^c   Shakiba, Yadollah ^c   Kiani, Amir ^d   Jamshidi, Ahmad Reza ^e   Boroushaki, Mohammad Taher ^a,b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DAS 28; Inflammation; Neopterin; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; NEOPTERIN; PROTEIN ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE ASSOCIATION; DISEASE DURATION; FAMILY HISTORY; FEMALE; GENDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; ONSET AGE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VISUAL ANALOG SCALE;

ACR; AMERICAN COLLEGE OF RHEUMATOLOGY; ANTI CITRULINATED PROTEIN ANTIBODY; ANTI CYCLIC CITRULINATED PEPTIDE ANTIBODY; ANTI-CCP; ANTI-CPA; C REACTIVE PROTEIN; CRP; DAS-28; DISEASE ACTIVITY SCORE-28; EDTA; ERYTHROCYTE SEDIMENTATION RATE; ESR; ETHYLENEDIAMINE TETRAACETIC ACID; GTP; GUANOSINE TRIPHOSPHATE; HIGH PRESSURE LIQUID CHROMATOGRAPHY; HPLC; IFN-Γ; INFLAMMATION; INTERFERON GAMMA; NEOPTERIN; RA; RF; RHEUMATOID ARTHRITIS; RHEUMATOID FACTOR; VAS; VISUAL ANALOG SCALE;

ADULT; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NEOPTERIN; PEPTIDES, CYCLIC;

EID: 84884681655     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.08.022     Document Type: Article

References (28)

1. E. Neumann, S. Lefèvre, B. Zimmermann, S. Gay, and U. Müller-Ladner Rheumatoid arthritis progression mediated by activated synovial fibroblasts Trends Mol Med 16 10 2010 458 468
2. K.P. Liao, and D.H. Solomon Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis Rheumatology (Oxford) 52 1 2013 45 52
3. G. Steiner Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools Clin Rev Allergy Immunol 32 1 2007 23 36
4. G.S. Firestein Immunologic mechanisms in the pathogenesis of rheumatoid arthritis J Clin Rheumatol 11 3 Suppl. 2005 S39 S44
5. W.J. Van Venrooij, J.J. van Beers, and G.J. Pruijn Anti-CCP antibodies: the past, the present and the future Nat Rev Rheumatol 7 7 2011 391 398
6. C. Murr, B. Widner, B. Wirleitner, and D. Fuchs Neopterin as a marker for immune system activation Curr Drug Metab 3 2 2002 175 187 (Pubitemid 34326529)
7. Y.H. Rho, J. Solus, P. Raggi, A. Oeser, T. Gebretsadik, and A. Shintani Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis Arthritis Care Res (Hoboken) 63 4 2011 535 541
8. K.K. Ray, D.A. Morrow, M.S. Sabatine, A. Shui, N. Rifai, and C.P. Cannon Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome Circulation 115 24 2007 3071 3078 (Pubitemid 46956496)
9. K. Sugioka, T. Naruko, T. Hozumi, M. Nakagawa, C. Kitabayashi, and Y. Ikura Elevated levels of neopterin are associated with carotid plaques with complex morphology in patients with stable angina pectoris Atherosclerosis 208 2 2010 524 530
10. E. Inoue, H. Yamanaka, M. Hara, T. Tomatsu, and N. Kamatani Comparison of disease activity score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values Ann Rheum Dis 66 3 2007 407 409 (Pubitemid 46579645)
11. M.L. Prevoo, M.A. van't Hof, H.H. Kuper, M.A. van Leeuwen, L.B. van de Putte, and P.L. van Riel Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 1 1995 44 48
12. C. Carru, A. Zinellu, S. Sotgia, R. Serra, M.F. Usai, and G.F. Pintus A new HPLC method for serum neopterin measurement and relationships with plasma thiols levels in healthy subjects Biomed Chromatogr 18 6 2004 360 366 (Pubitemid 39144695)
13. L.E. D'agostino, F. Ventimiglia, J.A. Verna, L. Colina Ade, Y. Aguirre, and A. Arturi Correlation between DAS-28 and neopterin as a biochemical marker of immune system activation in early rheumatoid arthritis Autoimmunity 46 1 2013 44 49
14. Y. Ozkan, G. Mete, A. Sepici-Dincel, V. Sepici, and B. Simsek Tryptophan degradation and neopterin levels in treated rheumatoid arthritis patients Clin Rheumatol 31 1 2012 29 34
15. K. Schroecksnadel, S. Kaser, M. Ledochowski, G. Neurauter, E. Mur, and M. Herold Increased degradation of tryptophan in blood of patients with rheumatoid arthritis J Rheumatol 30 9 2003 1935 1939 (Pubitemid 37075539)
16. K. Schroecksnadel, C. Winkler, C. Duftner, B. Wirleitner, M. Schirmer, and D. Fuchs Tryptophan degradation increases with stage in patients with rheumatoid arthritis Clin Rheumatol 25 3 2006 334 337
17. K. Esalatmanesh, R. Jamali, A. Jamali, B. Jamali, and M. Nikbakht Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis Rheumatol Int 32 12 2012 3799 3805
18. H. Li, W. Song, Y. Li, Y. Liu, J. Bai, and X. Li Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity Clin Rheumatol 29 4 2010 413 417
19. M. Puszczewicz, and C. Iwaszkiewicz Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis Arch Med Sci 7 2 2011 189 194
20. A. Raptopoulou, P. Sidiropoulos, M. Katsouraki, and D.T. Boumpas Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts Crit Rev Clin Lab Sci 44 4 2007 339 363 (Pubitemid 46897707)
21. L.A. Trouw, E.M. Haisma, E.W. Levarht, D. van der Woude, A. Ioan-Facsinay, and M.R. Daha Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways Arthritis Rheum 60 7 2009 1923 1931
22. M. Couderc, S. Mathieu, B. Pereira, B. Glace, and M. Soubrier Predictive factors of rituximab response in rheumatoid arthritis: results from a French university hospital Arthritis Care Res (Hoboken) 65 4 2013 648 652
23. J. Narvaez, C. Díaz-Torné, J.M. Ruiz, M.V. Hernandez, V. Torrente-Segarra, and S. Ros Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs Clin Exp Rheumatol 29 6 2011 991 997
24. K. Chatzidionysiou, E. Lie, E. Nasonov, G. Lukina, M.L. Hetland, and U. Tarp Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries Ann Rheum Dis 70 9 2011 1575 1580
25. T.B. Niewold, M.J. Harrison, and S.A. Paget Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis QJM 100 4 2007 193 201 (Pubitemid 47061687)
26. C. Alessandri, R. Priori, M. Modesti, R. Mancini, and G. Valesini The role of anti-cyclic cytrullinate antibodies testing in rheumatoid arthritis Clin Rev Allergy Immunol 34 1 2008 45 49
27. C. Alessandri, M. Bombardieri, N. Papa, M. Cinquini, L. Magrini, and A. Tincani Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement Ann Rheum Dis 63 10 2004 1218 1221 (Pubitemid 39273496)
28. C.M. Forrest, A. Kennedy, T.W. Stone, N. Stoy, and L.G. Darlington Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment Adv Exp Med Biol 527 2003 287 295 (Pubitemid 38197654)